Weekly Digest – November 2024 Weekly Digest – November 2024 25 Nov 2024: The first-in-class FGFR3 ADC of Qide Pharma commences clinical trials The U.S. FDA has granted clinical trial approval for GQ1011 (AMB302), a first-in-class ADC targeting fibroblast growth […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id